Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
131
datasets available to search
ShareScore release 0.9.0
Dataset results
131 results for “MCF-7 breast cancer cells”
Fig. 7 in Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line
Fig. 7. Agarose gel electrophoresis of MCF-7 cell genomic DNA. 1, ladder marker; 2, negative control; 3, cyclophosphamide (CP)-treated; 4–7, ethanolic extracts of Mimosa caesalpiniifolia leaves (EEM) in different concentrations (5.0; 20.0; 160.0 and 320.0 μg/mL). The results are representative of three independent experiments carried out in the same conditions. DNA ladder formation indicates apoptosis as seen in lanes 3–7.
Fig. 6. MCF-7 in Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line
Fig. 6. MCF-7 cell death (%) after treatment with cyclophosphamide (CP, 550 μg/mL) and different concentrations (5.0–320.0 μg/mL) of the ethanolic extract of Mimosa caesalpiniifolia leaves (EEM) for 24 h, compared to the negative control cells (NC), estimated by the Fast green color dye exclusion. Results are expressed as mean ± SEM of three independent experiments. Different letters indicate significant differences (p <0.01) by the Tukey test. Inset: appearance of cells after fast green-hematoxylin–eosin staining; 1, living cell; 2, green dead cell. EEM treatment kills MCF-7 cells in a concentrationdependent manner.
Fig. 3 in Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line
Fig. 3. Morphology of MCF-7 cells stained with hematoxylin–eosin, after 24 and 48 h incubation. NC, negative control cells; CP, cells treated with 550 μg/mL cyclophosphamide; 5, 80 and 320, cells treated, respectively, with 5.0, 80.0 and 320.0 μg/mL ethanolic extract of Mimosa caenalpiniifolia leaves. All the pictures are typical of three independent experiments, each carried out under identical conditions. Bar = 5 μm. Arrow—nucleolus; R—rounding; CC—chromatin condensation.
Fig. 2. MCF-7 in Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line
Fig. 2. MCF-7 cell protein content decreasing (%), estimated by the sulforhodamine B assay, after treatment with cyclophosphamide (CP, 550 μg/mL) and different concentrations of the ethanolic extract of Mimosa caesalpiniifolia leaves (EEM 5.0 - 320.0 μg/mL) for 24 and 48 h. The results are expressed as mean ± SEM of three independent experiments. Different letters indicate significant differences (p <0.001) by the Tukey test. Protein content was calculated relative to the negative control and 320.0 μg/mL EEM produced the maximum effect.
Fig. 1 in Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line
Fig. 1. HPLC-DAD-ESI-MS analysis of the ethanolic extract of Mimosa caesalpiniifolia leaves. (A) UV 360 nm; (B) ESI-MS, base peak chromatogram, negative ion mode, m/z 100–1500. No additional peaks were detected when the UV trace was recorded at wavelengths down to 360 nm. Peaks assigned as m/z: 288.97, 318.00, and 576.77 were identified, respectively, as catechin, 2,3 dihydroquercetagetin, and procyanidin B2 [(epi)catechin–(epi)catechin)] (see structures).
Fig. 4. MCF-7 in Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line
Fig. 4. MCF-7 cell diameter (μm) after treatment with cyclophosphamide (CP, 550 μg/mL) and different concentrations (5.0–320.0 μg/mL) of the ethanolic extract of Mimosa caesalpiniifolia leaves (EEM) for 24 or 48 h, compared to the negative control cells (NC). Results are expressed as mean ± SEM of three independent experiments. Different letters indicate significant differences (p <0.01) by the Tukey test. Note cell-diameter reduction after treatment, in comparison to the negative control cells, thereby indicating EEM cytotoxicity.
Data from: Metabolites of n-Butylparaben and iso-Butylparaben exhibit estrogenic properties in MCF-7 and T47D human breast cancer cell lines
Two oxidized metabolites of n-butylparaben (BuP) and iso-butylparaben (IsoBuP) discovered in human urine samples exhibit structural similarity to endogenous estrogens. We hypothesized that these metabolites bind to the human estrogen receptor (ER) and promote estrogen signaling. We tested this using models of ER-mediated cellular proliferation. The estrogenic properties of 3-hydroxy n-butyl 4-hydroxybenzoate (3OH) and 2-hydroxy iso-butyl 4-hydroxybenzoate (2OH) were determined using the ER-positive, estrogen-dependent human breast cancer cell lines MCF-7, and T47D. The 3OH metabolite induced cellular proliferation with EC50 of 8.2 µM in MCF-7 cells. The EC50 for 3OH in T47D cells could not be reached. The 2OH metabolite induced proliferation with EC50 of 2.2 µM and 43.0 µM in MCF-7 and T47D cells, respectively. The EC50 for the parental IsoBuP and BuP was 0.30 and 1.2 µM in MCF-7 cells, respectively. The expression of a pro-proliferative, estrogen-inducible gene (GREB1) was induced by these compounds and blocked by co-administration of an ER antagonist (ICI 182, 780), confirming the ER-dependence of these effects. The metabolites promoted significant ER-dependent transcriptional activity of an ERE-luciferase reporter construct at 10 and 20 µM for 2OH and 10 µM for 3OH. Computational docking studies showed that the paraben compounds exhibited the potential for favorable ligand-binding domain interactions with human ERα in a manner similar to known x-ray crystal structures of 17ß-estradiol in complex with ERα. We conclude that the hydroxylated metabolites of BuP and IsoBuP are weak estrogens and should be considered as additional components of potential endocrine disrupting effects upon paraben exposure.
Supplementary material 3 from: Khalaf WY, Elias RS, Raheem LA (2023) Design, synthesis and molecular docking study of coumarin pyrazoline derivatives against MCF-7 breast cancer cell line. Pharmacia 70(4): 1497-1492. https://doi.org/10.3897/pharmacia.70.e108670
Data synthesis compounds, physicochemical properties and identification of synthesis compound
Supplementary material 1 from: Khalaf WY, Elias RS, Raheem LA (2023) Design, synthesis and molecular docking study of coumarin pyrazoline derivatives against MCF-7 breast cancer cell line. Pharmacia 70(4): 1497-1492. https://doi.org/10.3897/pharmacia.70.e108670
Synthesis compounds
Supplementary material 2 from: Khalaf WY, Elias RS, Raheem LA (2023) Design, synthesis and molecular docking study of coumarin pyrazoline derivatives against MCF-7 breast cancer cell line. Pharmacia 70(4): 1497-1492. https://doi.org/10.3897/pharmacia.70.e108670
Docking study
Data from: Metabolites of n-Butylparaben and iso-Butylparaben exhibit estrogenic properties in MCF-7 and T47D human breast cancer cell lines
Open the record for dataset details and reuse information.
Next Generation Sequencing Analysis of Breast Cancer Cell Line MCF-7 And MDA-MB-231 After PI3K Inhibition
GEO Series GSE221833. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Effect of cold atmospheric plasma (CAP) in MCF-7/TxR breast cancer cell [dataset 2]
GEO Series GSE131478. Homo sapiens. 2 samples. Type: Expression profiling by array.
miRNA transcriptome profiling of spheroid-enriched cells with cancer stem cell properties in human breast MCF-7 cell line
GEO Series GSE68246. Homo sapiens. 6 samples. Type: Non-coding RNA profiling by high throughput sequencing.
Genome-Wide Mapping Of Time-Series ChIP-Seq Data For Human ERα Breast Cancer Cell Line (MCF-7)
GEO Series GSE35109. Homo sapiens. 4 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
RNA-sequencing for the characterization of the transcriptome of MCF-7-derived mammospheres and parental breast cancer cells.
GEO Series GSE182532. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Breast cancer MCF-7 cells and MDA-MB-231 cells: LNA-antimiR-21 transfected cells vs. LNA-control transfected cells
GEO Series GSE20627. Homo sapiens. 2 samples. Type: Expression profiling by array.
Identification of KDM3A regulated genes in the ER positive breast cancer cell line MCF-7
GEO Series GSE68918. Homo sapiens. 11 samples. Type: Expression profiling by array.
Comparison of GATA3 mutant and GATA3 wild type isogenic MCF-7 and CAMA1 breast cancer cell lines
GEO Series GSE101780. Homo sapiens. 13 samples. Type: Expression profiling by array.
Bulk RNA-sequencing of transduced colorectal cancer cell line HCT-116 and breast cancer cell line MCF-7 overexpressing full-lenght p53β or p53β-stop-lost.
GEO Series GSE250000. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.